KRAS and pancreatic neoplasm: Taken together, our findings suggest that the transcription factor Jdp2 plays a key role in AhR and Nrf2 activation to maintain ROS balance, cell migration and spreading, and cancer regression in a mouse model of Kras–Trp53 pancreatic cancer [30].